A phase I study of AB 101 (Insulin) in patients with type 2 diabetes mellitus

Trial Profile

A phase I study of AB 101 (Insulin) in patients with type 2 diabetes mellitus

Planning
Phase of Trial: Phase I

Latest Information Update: 10 Dec 2015

At a glance

  • Drugs Insulin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Dec 2015 According to a media release, AntriaBio will use the proceeds from a private placement transaction for phase I trials of AB101 in patients with type 1 and type 2 diabetes.
    • 19 Nov 2015 New trial record
    • 17 Nov 2015 According to an AntriaBio media release, company is planning to file an IND application with the U.S. FDA for AB101 and planning to initiate this and other trial (see profile 252952) in 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top